Familial Breast Cancer susceptibility / Fanconi anemia, complementation group N
Definition
The PALB2 gene (FANCN) encodes a protein that binds to the BRCA2 protein and localizes it to sites of DNA double-strand break repair. In women carrying a monoallelic germline variant, the lifetime risk of breast cancer rises to ~35-40% (~12% in the general population); biallelic variants lead to Fanconi anemia complementation group N, with bone marrow failure, congenital anomalies and childhood cancer predisposition.
Gene/region examined
PALB2 - Whole Gene
Method
Sequence analysis
Accepted sample types
EDTA blood, AF, CVS
Inheritance
Hereditary; a monoallelic variant is inherited as autosomal dominant breast/pancreatic cancer susceptibility, while biallelic variants are inherited as autosomal recessive (AR) Fanconi anemia.